Agreements reached under this partnership
Business alliance- 1
Observational study on improving the uterine environment in broodmares
- 2
Evaluation of potential applications for inflammatory conditions, including PMIE (persistent mating-induced endometritis)
- 3
Evaluation of the usefulness of cell-derived components in the breeding field
- 4
Accumulation of case data and veterinary analysis
- 5
Collection of medical evidence toward out-licensing Neocella overseas
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of the execution of this agreement on the Company's financial results is expected to be minor at this time.
| Item | Details |
|---|---|
| Name of alliance partner | Northern Farm |
| Alliance partner's business activities | Racehorse production, training and breeding |
| Alliance partner's location | Abira Town, Yufutsu County, Hokkaido |
| Type of alliance | Business alliance |
| Details of the alliance | Observational study on improving the uterine environment in broodmares, Evaluation of potential applications for inflammatory conditions, including PMIE (persistent mating-induced endometritis), Evaluation of the usefulness of cell-derived components in the breeding field, Accumulation of case data and veterinary analysis, Collection of medical evidence toward out-licensing Neocella overseas |
| Contract Date | 19 May 2026 |
| Alliance start date | 19 May 2026 |
| Impact on Business Performance | The impact of the execution of this agreement on the Company's financial results is expected to be minor at this time. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To examine the potential for improving the uterine environment using Neocella in inflammatory conditions, including refractory endometritis, in the racehorse breeding field. The parties will also conduct commercialization research in the racehorse breeding field and collect medical evidence toward out-licensing Neocella overseas.